Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

[Autism and ADHD across the life span. Differential diagnoses or comorbidity?].

Banaschewski T, Poustka L, Holtmann M.

Nervenarzt. 2011 May;82(5):573-80. doi: 10.1007/s00115-010-3239-6. Review. German.

PMID:
21484168
2.

[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].

Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.

Neuropsychiatr. 2007;21(3):187-206. Review. German.

PMID:
17915180
3.

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, Pamulapati S, Buitelaar JK, Hoekstra PJ.

J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733-41. doi: 10.1016/j.jaac.2012.04.011. Epub 2012 May 25.

PMID:
22721596
4.

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.

Harfterkamp M, Buitelaar JK, Minderaa RB, van de Loo-Neus G, van der Gaag RJ, Hoekstra PJ.

J Child Adolesc Psychopharmacol. 2013 Apr;23(3):194-9. doi: 10.1089/cap.2012.0012. Epub 2013 Apr 11.

PMID:
23578015
5.

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

Troost PW, Steenhuis MP, Tuynman-Qua HG, Kalverdijk LJ, Buitelaar JK, Minderaa RB, Hoekstra PJ.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):611-9.

PMID:
17069549
6.
7.

[Autism and attention deficit hyperactivity disorder: pharmacological intervention].

Fernández-Jaén A, Martín Fernández-Mayoralas D, Fernández-Perrone AL, Calleja-Pérez B, Muñoz-Jareño N, López-Arribas S.

Rev Neurol. 2013 Sep 6;57 Suppl 1:S205-10. Review. Spanish.

8.

The comorbidity of ADHD and autism spectrum disorder.

Antshel KM, Zhang-James Y, Faraone SV.

Expert Rev Neurother. 2013 Oct;13(10):1117-28. doi: 10.1586/14737175.2013.840417. Review.

PMID:
24117274
9.

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.

Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):599-610.

PMID:
17069548
10.

Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.

Hazell P, Zhang S, Wolańczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D.

Eur Child Adolesc Psychiatry. 2006 Mar;15(2):105-10.

PMID:
16523251
11.

A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

Treuer T, Gau SS, Méndez L, Montgomery W, Monk JA, Altin M, Wu S, Lin CC, Dueñas HJ.

J Child Adolesc Psychopharmacol. 2013 Apr;23(3):179-93. doi: 10.1089/cap.2012.0093. Epub 2013 Apr 6. Review.

12.

Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.

Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97-110. doi: 10.1089/cap.2009.0111. Epub 2011 Apr 13.

PMID:
21488751
13.

Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.

Murray MJ.

Curr Psychiatry Rep. 2010 Oct;12(5):382-8. doi: 10.1007/s11920-010-0145-3. Review.

PMID:
20694583
15.

Impact of ADHD symptoms on autism spectrum disorder symptom severity.

Sprenger L, Bühler E, Poustka L, Bach C, Heinzel-Gutenbrunner M, Kamp-Becker I, Bachmann C.

Res Dev Disabil. 2013 Oct;34(10):3545-52. doi: 10.1016/j.ridd.2013.07.028. Epub 2013 Aug 22.

PMID:
23973801
17.

Atomoxetine for treating ADHD symptoms in autism: a systematic review.

Ghanizadeh A.

J Atten Disord. 2013 Nov;17(8):635-40. doi: 10.1177/1087054712443154. Epub 2012 Apr 27. Review.

PMID:
22544388
18.

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder.

Handen BL, Taylor J, Tumuluru R.

Int J Adolesc Med Health. 2011;23(3):167-73. Review.

PMID:
22191179
20.

Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder.

Zeiner P, Gjevik E, Weidle B.

Acta Paediatr. 2011 Sep;100(9):1258-61. doi: 10.1111/j.1651-2227.2011.02263.x. Epub 2011 Apr 6.

PMID:
21392103

Supplemental Content

Support Center